Thursday, 25 February 2021

Transasia showcases diagnostic solutions at MAPCON 2018

11 September 2018 | News

Transasia exhibits its latest advancements for pathologists and clinicians

Representative Image

Representative Image

At the recently concluded MAPCON, Transasia offered the attending pathologists an opportunity to gain insights into the latest advancements in the in-vitro diagnostic industry.

In its 39th year, the Annual Conference of the Maharashtra Chapter of IAPM (MAPCON) was held between 7 th and 9 th September, 2018 and hosted by the Armed Forces Medical College (AFMC), Pune.

As the principal partner, Transasia organized two scientific sessions: Acquired bleeding disorders by Dr. (Col.) Jyoti Kotwal, Sr. Consultant, Dept. of Hematology, SGRH and GRIPMER, New Delhi and Pathophysiology and diagnosis of Hemophilia by Dr. Swati Pai, Head of Dept. Lab Medicine, Manipal Hospitals, Bengaluru.

At its booth, Transasia commemorated the trust, commitment and service of the armed forces. It further harnessed its position as a leader in the Indian IVD Industry by showcasing its latest and best technologies.

‘Make in India’, fully automated biochemistry analyzers, XL-1000 and EM 200 and coagulation analyzer ECL 760 were on display. Additionally, Hb-Vario, its HPLC system and urine chemistry systems, Laura XL and Laura Smart were also exhibited alongwith the automated ESR system, Vesmatic Easy. Transasia is the sole distributor in India of the world-class Sysmex hematology analyzers, of which the 3 PDA, XP-100 and 6 PDA, XN 330 were showcased.

Further, Transasia’s rapid diagnostic kits, that offer unmatched sensitivity and specificity for dengue and malaria detection were well received at the booth.

Besides quality products and solutions, Transasia also provides a sophisticated LIMS, through its information technology partner, CAREDATA. At the booth, the CAREDATA team offered the visiting delegates solutions for enhanced lab efficiency.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls